Home / Cancer and immune system / Trametinib
ATC L01EE01 · Mitogen-activated Protein Kinase (MEK) Inhibitors · updated 6 Nov 2026
Trametinib shortage
As of 6 Nov 2026, Trametinib has a reported shortage in 1 of the 16 countries we track (Italy), covering 1 product from 1 company.
Is there a Trametinib shortage?
Yes. As of 6 Nov 2026, Trametinib is reported short in 1 of the 16 countries we track: Italy. The earliest expected return is 20 Nov 2026 (Italy). New since 7 Oct 2026: Italy.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Novartis NOVN · SIX Swiss
Compared with similar medicines
ATC group L01EE · Mitogen-activated Protein Kinase (MEK) InhibitorsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | SPEXOTRAS | NOVARTIS EUROPHARM LIMITED | 5 Nov 2026 | 20 Nov 2026 | Increased demand Elevata richiesta/problemi produttivi |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there a Trametinib shortage?
Yes. As of 6 Nov 2026, Trametinib is reported short in 1 of the 16 countries we track: Italy. The earliest expected return is 20 Nov 2026 (Italy). New since 7 Oct 2026: Italy.
When will Trametinib be back in stock?
Companies expect supply back from 20 Nov 2026 in Italy; Italy: 20 Nov 2026. These are company estimates reported to each authority.
Why is Trametinib in short supply?
The most common reason reported is: increased demand. Reasons by product are listed in the table below.
Which companies have Trametinib shortages?
Novartis.